Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Microbot Medical Inc. (MBOT : NSDQ)
 
 • Company Description   
Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.

Number of Employees: 21

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.50 Daily Weekly Monthly
20 Day Moving Average: 1,237,265 shares
Shares Outstanding: 36.38 (millions)
Market Capitalization: $90.94 (millions)
Beta: 1.13
52 Week High: $3.38
52 Week Low: $0.82
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -9.42% -13.15%
12 Week 51.51% 32.77%
Year To Date 123.21% 110.82%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
175 DERBY ST. BLD. 27
-
HINGHAM,MA 02043
USA
ph: 781-875-3605
fax: 781-556-5347
ir@microbotmedical.com http://www.microbotmedical.com
 
 • General Corporate Information   
Officers
Harel Gadot - Chief Executive Officer; Chairman and President
Rachel Vaknin - Chief Financial Officer
Scott Burell - Director
Martin Madden - Director
Prattipati Laxminarain - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 59503A204
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 36.38
Most Recent Split Date: 9.00 (0.07:1)
Beta: 1.13
Market Capitalization: $90.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.32 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.00
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 52.94%
vs. Previous Quarter: 60.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -110.27
12/31/24 - -234.01
ROA
06/30/25 - -
03/31/25 - -94.20
12/31/24 - -175.78
Current Ratio
06/30/25 - -
03/31/25 - 16.19
12/31/24 - 2.37
Quick Ratio
06/30/25 - -
03/31/25 - 16.19
12/31/24 - 2.37
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - 0.83
12/31/24 - 0.17
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©